235
Views
2
CrossRef citations to date
0
Altmetric
Pharmacology

Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan

, , ORCID Icon, , , , ORCID Icon, , & ORCID Icon show all
Pages 595-605 | Received 27 Oct 2021, Accepted 09 Feb 2022, Published online: 03 Mar 2022

References

  • Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437–453.
  • UMC. WHO programme for international drug monitoring. Geneva: Uppsala Monitoring Centre; 2019.
  • Chokshi A, Sifri Z, Cennimo D, et al. Global contributors to antibiotic resistance. J Glob Infect Dis. 2019;11(1):36–42.
  • Patsuree A, Krska J, Jarernsiripornkul N. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand. Expert Opin Drug Saf. 2016;15(3):287–295.
  • Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140–156.
  • World Health Organization. Quality A, safety of medicines T. Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action. Geneva: World Health Organization; 2002.
  • Elkalmi RM, Hassali MA, Ibrahim MIM, et al. Pharmacy students’ knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ. 2011;75(5):96.
  • Oreagba IA, Ogunleye OJ, Olayemi SO. The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, South West Nigeria. Pharmacoepidemiol Drug Saf. 2011;20(1):30–35.
  • Shanko H, Abdela J. Knowledge, attitudes, and practices of health care professionals toward adverse drug reaction reporting in Hiwot Fana specialized university hospital, Harar, Eastern Ethiopia: a cross-sectional study. Hosp Pharm. 2018;53(3):177–187.
  • Güner MD, Ekmekci PE. Healthcare professionals' pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8(1):13–20.
  • Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19–31.
  • Hussain R, Hassali MA, Hashmi F, et al. Qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore. Pakistan. J Pharm Policy Pr. 2018;11:16.
  • Biswas P. Pharmacovigilance in Asia. J Pharmacol Pharmacother. 2013;4(Suppl 1):S7–S19.
  • Data for lower middle income, Pakistan|Data [Internet] [cited 2021 Aug 26]. Available from: https://data.worldbank.org/?locations=XN-PK
  • GBD Healthcare Access and Quality Collaborators. Measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations: a systematic analysis from the global burden of disease study 2016. Lancet. 2018;391(10136):2236–2271.
  • Nisa ZU, Zafar A, Sher F. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the Capital of Pakistan. Saudi Pharm J. 2018;26(4):453–461.
  • Hussain R, Hassali MA, Hashmi F, et al. Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey. J Pharm Policy Pr. 2021;14(1):5.
  • Abdel-Latif MM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, kingdom of Saudi Arabia. Saudi Pharm J. 2015;23(2):154–161.
  • Sample size calculator by Raosoft, Inc. [Internet] [cited 2019 Jul 21]. Available from: http://www.raosoft.com/samplesize.html
  • Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: knowledge, attitudes and perceptions amongst resident doctors. J Pharm Sci Res. 2011;3(2):1064.
  • Awodele O, Akinyede A, Adeyemi OA, Awodele DF. Pharmacovigilance amongst doctors in private hospitals in Lagos west senatorial district, Nigeria. Int J Risk Amp Saf Med. 2011;23(4):217–226.
  • Sharma R. Article details study of key stakeholders for their knowledge, attitude and practice on adverse drug reaction reporting in tertiary care hospitals in Jaipur, India. IJP. 2017;2(2):1–11.
  • Sahu RK, Yadav R, Prasad P, et al. Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. Springerplus. 2014;3:695.
  • Abu Hammour K, El-Dahiyat F, Abu Farha R. Health care professionals knowledge and perception of pharmacovigilance in a tertiary care teaching hospital in Amman, Jordan. J Eval Clin Pract. 2017;23(3):608–613.
  • Alshammari TM, Alamri KK, Ghawa YA, et al. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia. Int J Clin Pharm. 2015;37(6):1104–1110.
  • Gupta SK, Nayak RP, Shivaranjani R, et al. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6(1):45–52.
  • Hussain R, Hassali MA, Babar Z-U-D. Quantitative methods in pharmacy practice research. In: Babar Z-U-D, editor. Encyclopedia of pharmacy practice and clinical pharmacy. Oxford: Elsevier; 2019. p. 22–28.
  • Department of Health Khyber-Pakhtunkhwa. Health Policy Khyber-Pakhtunkhwa [Internet]; 2018. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/viewer.html?pdfurl=http%3A%2F%2Fhealthkp.gov.pk%2Fpublic%2Fuploads%2Fdownloads-41.pdf&clen=532627&chunk=true
  • Kassa Alemu B, Biru TT. Health care professionals’ knowledge, attitude, and practice towards adverse drug reaction reporting and associated factors at selected public hospitals in northeast Ethiopia: a cross-sectional study. BioMed Res Int. 2019;2019:1–11.
  • Salehi T, Seyedfatemi N, Mirzaee MS, et al. Nurses’ knowledge, attitudes, and practice in relation to pharmacovigilance and adverse drug reaction reporting: a systematic review. Biomed Res Int. 2021;2021:6630404.
  • Lemay J, Alsaleh FM, Al-Buresli L, et al. Reporting of adverse drug reactions in primary care settings in Kuwait: a comparative study of physicians and pharmacists. Med Princ Pract. 2018;27(1):30–38.
  • Hussain R, Hassali MA, Ur Rehman A, et al. A qualitative evaluation of adverse drug reaction reporting system in Pakistan: findings from the nurses’ perspective. Int J Env Res Public Health. 2020;17(9):3039.
  • Babar Z-U-D, Scahill SL, Akhlaq M, et al. A bibliometric review of pharmacy education literature in the context of low-to middle-income countries. Curr Pharm Teach Learn. 2013;5(3):218–232.
  • DRAP. Pakistan National Pharmacovigilance Guidelines 1st ed [Internet]; 2019. Available from: https://efaidnbmnnnibpcajpcglclefindmkaj/viewer.html?pdfurl=https%3A%2F%2Fdra.gov.pk%2Fdocs%2FDraft%2520Pakistan%2520National%2520Pharmacovigigilance%2520guidlines%25204-9-2019.pdf&clen=3021294&chunk=true
  • Shamim S, Sharib SM, Malhi SM, et al. Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists. Springerplus. 2016;5(1):1778.
  • Palaian S, Ibrahim MI, Mishra P. Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract. 2011;9(4):228–235.
  • AlShammari TM, Almoslem MJ. Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-Centre cross sectional study. Saudi Pharm J. 2018;26(7):925–931.
  • Hussain R, Hassali MA, Ur Rehman A, et al. Physicians’ understanding and practices of pharmacovigilance: qualitative experience from a lower Middle-Income country. Int J Env Res Public Health. 2020;17(7):2209.
  • Mulatu WN, Alemayehu W. Assessment of knowledge, attitude and practice of health professionals towards adverse drug reaction reporting and factors associated with reporting. J Pharmacovigil. 2014;2(4):1–7.
  • Amrain M, Bečić F. Knowledge, perception, practices and barriers of healthcare professionals in Bosnia and Herzegovina towards adverse drug reaction reporting and pharmacovigilance. JHSCI. 2014;4(2):120–125.
  • Roberts PI, Wolfson DJ, Booth TG. The role of pharmacists in adverse drug reaction reporting. Drug Saf. 1994;11(1):7–11.
  • Shekelle PG, Wachter RM, Pronovost PJ, et al. Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Evid Rep Technol Assess. 2013;(211):1–945.
  • Hadi MA, Neoh CF, Zin RM, Elrggal ME, et al. Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract. 2017;6:91–98.
  • Osemene KP, Ayeni MI, Afolabi MO. The role of community pharmacists in monitoring adverse drug reactions in Nigeria. J Pharm Health Serv Res. 2012;3(4):197–204.
  • Calvert R. Clinical pharmacy–a hospital perspective. Br J Clin Pharmacol. 1999;47(3):231–238.
  • Schlienger RG, Lüscher TF, Haefeli WE, et al. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21(3):110–115.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.